NeuralStudio
NeuralStudio Raises $500M Series E to Transform HealthTech
Quick Facts
NeuralStudio Raises $500M Series E in Latest Funding Round
NeuralStudio has successfully closed a $500M Series E funding round, marking a significant milestone in the company's growth trajectory. The round was led by Insight Partners, with participation from Andreessen Horowitz.
Company Overview
Founded in 2024 and headquartered in Austin, TX, NeuralStudio has established itself in the HealthTech space. Leading clinical decision support system enhancing medical accuracy with AI
With a current valuation of $5B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $500M Series E
- Valuation: $5B
- Lead Investor: Insight Partners
Future Outlook
As NeuralStudio moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the healthtech space.
Key Investors
About the Author
Related Company Reports
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
Invitae Headquarters - Office Location & Address
Discover Invitae's headquarters at 1400 16th St, San Francisco, CA 94103. Medical genetic testing. Learn about the office facilities and work environment.
Color Genomics Headquarters - Office Location & Address
Discover Color Genomics's headquarters at 863 Mitten Rd, Burlingame, CA 94010. Population genomics and genetic testing. Learn about the office facilities and work environment.